Global adoption of extended non-invasive prenatal screening will require large-scale validation, but could transform obstetric care from reactive to preventive, personalised medicine.
Thanks to Kate Stanley and Joris Vermeesch for the collaboration, and @natgenet.nature.com for the opportunity!

Also epigenetic signals are present which predict the risk of preeclampsia, intra-uterine growth retardation, gestational diabetes and preterm birth, as well as pregnancy-related immune-mediated disease. Finally, also viral infections can be gleaned from these analyses.